Search Results for 'Biosimilars-Regulation-And-Litigation'

Biosimilars-Regulation-And-Litigation published presentations and documents on DocSlides.

ASBM Biosimilars US Prescribers and Biosimilars Naming
ASBM Biosimilars US Prescribers and Biosimilars Naming
by min-jolicoeur
Kevin Olson, CEO. Industry Standard Research. Kev...
Biosimilars   & EU  regulation
Biosimilars & EU regulation
by karlyn-bohler
Alice DOMINIQUE - M2 AREIPS. 1. Content. 2. Defin...
Biosimilars  are effective and safe and should immediately replace innovator molecules in the NHS
Biosimilars are effective and safe and should immediately replace innovator molecules in the NHS
by myesha-ticknor
Dr Chris Deighton. Consultant Rheumatologist . Co...
Biosimilars in emerging markets- regulatory and Commercial considerations
Biosimilars in emerging markets- regulatory and Commercial considerations
by jane-oiler
OMIC Group. Biosimilars 2104. Hyderabad. India. 2...
  What is the value of Real-World Evidence for Biosimilars?
  What is the value of Real-World Evidence for Biosimilars?
by bitsy
Disclaimer. This panel is moderated by Dr. Delphin...
Synergy Satellite Event - Biosimilars in colorectal cancer
Synergy Satellite Event - Biosimilars in colorectal cancer
by mia
– what's your gut feeling?. 25th Anniversary EAH...
Building a  Biosimilars  Pathway in the U.S.
Building a Biosimilars Pathway in the U.S.
by attentionallianz
Richard . Dolinar. , MD. Endocrinologist, Chairman...
Application of Biosimilars in RA IN Clinical Practice:
Application of Biosimilars in RA IN Clinical Practice:
by conchita-marotz
Key Issues and Challenges.  . Introduction. Diff...
Applying Biosimilars in Hematologic Cancers
Applying Biosimilars in Hematologic Cancers
by conchita-marotz
This program will include a discussion of off-lab...
Biosimilars in the Real World
Biosimilars in the Real World
by liane-varnes
Introduction/Overview . PLANETRA Extension Study:...
US Regulatory Pathway For Biosimilars
US Regulatory Pathway For Biosimilars
by cheryl-pisano
Practical Legal/Regulatory Considerations Arising...
Biosimilars in RA:  A Blessing or a Curse?
Biosimilars in RA: A Blessing or a Curse?
by conchita-marotz
Introduction/Overview . What Is a Biosimilar?. Di...
ASBM Biosimilars
ASBM Biosimilars
by phoebe-click
US Prescribers and Biosimilars Naming. Kevin Olso...
Biosimilars
Biosimilars
by lindy-dunigan
Knowledge Connect Slide Resource. This slide dec...
Latin American Biologics/Biosimilars Conference
Latin American Biologics/Biosimilars Conference
by giovanna-bartolotta
Presented by . the Alliance for Safe Bioloigic . ...
A QUM partnership approach to regulating
A QUM partnership approach to regulating
by liane-varnes
biosimilars. in Australia. David Lim, Evan Siege...
Biosimilars: Regulation and Litigation
Biosimilars: Regulation and Litigation
by mitsue-stanley
Agenda. Key Regulatory Exclusivities for Biologic...
Litigation Management Software Solution for Legal Departments
Litigation Management Software Solution for Legal Departments
by casefox
Are you looking to automate and manage your legal ...
Managing Litigation Support Without a Litigation Support De
Managing Litigation Support Without a Litigation Support De
by trish-goza
Panelists. Michael Goldstein – . Lan. . Infote...
Los Angeles Business Litigation Attorney
Los Angeles Business Litigation Attorney
by mathewandgeorge
For nearly two decades, Mathew George has success...
About OMICS Group       OMICS Group International is an amalgamation of 
About OMICS Group OMICS Group International is an amalgamation of 
by sherrill-nordquist
Open Access publications.  and worldwide interna...
Budget impact and cost-effectiveness of oncology
Budget impact and cost-effectiveness of oncology
by roxanne
biosimilars. Prof. dr. Steven Simoens. Health econ...
Understanding Biologics Biologics and Biosimilars
Understanding Biologics Biologics and Biosimilars
by calandra-battersby
Animation: What Are Biologics?. Production of Bio...
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
by calandra-battersby
OMICS Group Biosimilars 2015 Birmingham, UK. 10-1...
Category 1: Defining Terms
Category 1: Defining Terms
by jasmine
Clue: . A biologic product with no clinically mean...
1 Immunogenicity   The key safety issue for biosimilars
1 Immunogenicity The key safety issue for biosimilars
by gelbero
Prof. Ibrahim A. . Alsarra. Professor . of . Phar...
CHALLENGES FACED IN THE DEVELOPMENT OF BIOSIMILARS
CHALLENGES FACED IN THE DEVELOPMENT OF BIOSIMILARS
by iamamercy
Dr.G.Hima. . Bindu. ...
Latin American Physician Perspectives on Biosimilars
Latin American Physician Perspectives on Biosimilars
by celsa-spraggs
Presented at the . Latin American Biologics/Biosi...
Bio similars A Presentation
Bio similars A Presentation
by kittie-lecroy
By. ANSHUL . SHARMA. Graduate Research Scholar. D...
PhAMA Position on Biosimilar Medicines
PhAMA Position on Biosimilar Medicines
by celsa-spraggs
Ms. Leah Goodman. Contents. Key Messages. An Over...
United Spinal Association
United Spinal Association
by alida-meadow
August, 2014. Biologics & Biosimilars: . An O...
Biological Products: concepts, naming,
Biological Products: concepts, naming,
by faustina-dinatale
interchangeability,extrapolation. and safety. Dr...
Acceptable changes in quality attributes of glycosylated bi
Acceptable changes in quality attributes of glycosylated bi
by debby-jeon
Schiestl M, Stangler T, Torella C, et al. . Nat B...
Biosimilars  in the united states – Update on FDA Impleme
Biosimilars in the united states – Update on FDA Impleme
by test
James C. Shehan. Hyman, Phelps & McNamara, P....
Distinguishable INNs: A Global Solution
Distinguishable INNs: A Global Solution
by trish-goza
Richard . Dolinar. , MD. Chairman, Alliance for S...
Andrew Zeve Litigation partner Bracewell Law
Andrew Zeve Litigation partner Bracewell Law
by amey
Title Allocation Wells in Texas Andrew Zeve co-cha...
A LEADER IN COMMERCIAL LITIGATION GAMING AND MOREMr Bice is a cofo
A LEADER IN COMMERCIAL LITIGATION GAMING AND MOREMr Bice is a cofo
by julia
400 S. 7th Street | Suite 300 Las Vegas, NV 89101
State and Local Tax Litigation Update
State and Local Tax Litigation Update
by celsa-spraggs
Antonio . Ferachi. – . Director, . Litigation ...
Litigation PR:  Bridging the Gap between Legal Liability and Reputation Rescue
Litigation PR: Bridging the Gap between Legal Liability and Reputation Rescue
by tatyana-admore
Evan Nierman. Founder, Red Banyan. PR Strategy ...
Litigation in Obstetrics and Gynaecology:
Litigation in Obstetrics and Gynaecology:
by jane-oiler
“Situational Awareness” and “Root Cause Ana...